Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
19 February 2018 Photo Danie Nel
Jeanri-Tine respected for her word on wine
Jeanri-Tine

Jeanri-Tine van Zyl may have the perfect career – an idyllic lifestyle that most of us only dream of. She is her own boss and is required to drink wine on the job! Jeanri-Tine is a respected wine writer. She obtained a BA Media Studies degree at Kovsies, before completing further qualifications in Stellenbosch and Cape Town. She is the owner/director of Feed That Bird Communication Consultants (Pty) Ltd. – a PR, communications and content marketing agency providing creative communication support to some of South Africa’s major wine brands and companies. 

My favourite career quote is by Charles Bukowski: “If you're going to try, go all the way. Otherwise, don’t even start. This could mean losing girlfriends, wives, relatives and maybe even your mind. It could mean not eating for three or four days. It could mean freezing on a park bench. It could mean jail. It could mean derision … And, you'll do it, despite rejection and the worst odds. And it will be better than anything else you can imagine.” 

“I didn’t realise it at the time,
but those three years at the
UFS were probably some of
my best, most formative years.”

The best career advice I got was probably from well-known wine critic Michael Fridjhon, who told me a story about an exceptionally talented ballerina who gave up ballet when she wasn’t cast as the lead in ‘Giselle’ It might not be what he intended, but I interpreted it as ‘if you can’t be the best in what you do, quit and try something else’.

I didn’t realise it at the time, but those three years at the UFS were probably some of my best, most formative years. I remember the sleepless weekends as IRAWA editor, marching into Ds Kiepie Jaftha’s office armed with demands for better security on campus, the endless wisdom and strength shared by Dr Elsabe Pepler, who was head of Communication at the Department at the time, and sitting on the grass with my friends before a test, knowing that no matter the outcome, we will all be okay…

 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept